244 related articles for article (PubMed ID: 35200603)
41. Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report.
Zhang G; Lin L; Dong D; Qiu H; Liu T; Lian L; Shen G
Medicine (Baltimore); 2021 Jan; 100(4):e24295. PubMed ID: 33530218
[TBL] [Abstract][Full Text] [Related]
42. Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers.
Haan JC; Buffart TE; Eijk PP; van de Wiel MA; van Wieringen WN; Howdle PD; Mulder CJ; van de Velde CJ; Quirke P; Nagtegaal ID; van Grieken NC; Grabsch H; Meijer GA; Ylstra B
Ann Oncol; 2012 Feb; 23(2):367-74. PubMed ID: 21586687
[TBL] [Abstract][Full Text] [Related]
43. Small bowel adenocarcinoma.
Zouhairi ME; Venner A; Charabaty A; Pishvaian MJ
Curr Treat Options Oncol; 2008 Dec; 9(4-6):388-99. PubMed ID: 19365735
[TBL] [Abstract][Full Text] [Related]
44. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
[TBL] [Abstract][Full Text] [Related]
45. Malignant tumours of the small intestine.
Reynolds I; Healy P; Mcnamara DA
Surgeon; 2014 Oct; 12(5):263-70. PubMed ID: 24637026
[TBL] [Abstract][Full Text] [Related]
46. Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma.
Quaas A; Heydt C; Waldschmidt D; Alakus H; Zander T; Goeser T; Kasper P; Bruns C; Brunn A; Roth W; Hartmann N; Bunck A; Schmidt M; Buettner R; Merkelbach-Bruse S
BMC Gastroenterol; 2019 Feb; 19(1):21. PubMed ID: 30717682
[TBL] [Abstract][Full Text] [Related]
47. Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations.
Pedersen KS; Raghav K; Overman MJ
J Natl Compr Canc Netw; 2019 Sep; 17(9):1135-1141. PubMed ID: 31487680
[TBL] [Abstract][Full Text] [Related]
48. Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.
Aparicio T; Svrcek M; Zaanan A; Beohou E; Laforest A; Afchain P; Mitry E; Taieb J; Di Fiore F; Gornet JM; Thirot-Bidault A; Sobhani I; Malka D; Lecomte T; Locher C; Bonnetain F; Laurent-Puig P
Br J Cancer; 2013 Dec; 109(12):3057-66. PubMed ID: 24196786
[TBL] [Abstract][Full Text] [Related]
49. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Locher C; Batumona B; Afchain P; Carrère N; Samalin E; Cellier C; Aparicio T; Becouarn Y; Bedenne L; Michel P; Parc Y; Pocard M; Chibaudel B; Bouché O;
Dig Liver Dis; 2018 Jan; 50(1):15-19. PubMed ID: 29174568
[TBL] [Abstract][Full Text] [Related]
50. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma.
Ye X; Zhang G; Chen H; Li Y
PLoS One; 2018; 13(8):e0200204. PubMed ID: 30096150
[TBL] [Abstract][Full Text] [Related]
51. Small bowel malignancies: a review of 29 patients at a single centre.
Kam MH; Barben CP; Eu KW; Seow-Choen F
Colorectal Dis; 2004 May; 6(3):195-7. PubMed ID: 15109386
[TBL] [Abstract][Full Text] [Related]
52. Primary small bowel malignancies: single-center results of three decades.
Ojha A; Zacherl J; Scheuba C; Jakesz R; Wenzl E
J Clin Gastroenterol; 2000 Apr; 30(3):289-93. PubMed ID: 10777190
[TBL] [Abstract][Full Text] [Related]
53. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma.
Zhang S; Yuan W; Zhang J; Chen Y; Zheng C; Ma J; Jiang Q; Zhao Y; Xu Q; Wang C
Medicine (Baltimore); 2017 Aug; 96(31):e7713. PubMed ID: 28767610
[TBL] [Abstract][Full Text] [Related]
55. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
[TBL] [Abstract][Full Text] [Related]
56. Prognostic clinicopathological factors after curative resection of small bowel adenocarcinoma.
Inoue Y; Hayashi M; Satou N; Miyamoto Y; Hirokawa F; Asakuma M; Shimizu T; Kayano H; Yamamoto M; Yamana H; Okuda J; Egashira Y; Tanigawa N
J Gastrointest Cancer; 2012 Jun; 43(2):272-8. PubMed ID: 21607548
[TBL] [Abstract][Full Text] [Related]
57. Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome.
Lech G; Korcz W; Kowalczyk E; Słotwiński R; Słodkowski M
Scand J Gastroenterol; 2017 Nov; 52(11):1194-1202. PubMed ID: 28737049
[TBL] [Abstract][Full Text] [Related]
58. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study.
Sakae H; Kanzaki H; Nasu J; Akimoto Y; Matsueda K; Yoshioka M; Nakagawa M; Hori S; Inoue M; Inaba T; Imagawa A; Takatani M; Takenaka R; Suzuki S; Fujiwara T; Okada H
Br J Cancer; 2017 Nov; 117(11):1607-1613. PubMed ID: 28982111
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.
Alvi MA; McArt DG; Kelly P; Fuchs MA; Alderdice M; McCabe CM; Bingham V; McGready C; Tripathi S; Emmert-Streib F; Loughrey MB; McQuaid S; Maxwell P; Hamilton PW; Turkington R; James JA; Wilson RH; Salto-Tellez M
Oncotarget; 2015 Aug; 6(25):20863-74. PubMed ID: 26315110
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive genomic profiling of small bowel adenocarcinoma by tissue and plasma biopsy.
Yu D; Wang J; Zheng B; Yuan M; Gu D; Chen R; Chen X
Genomics; 2024 Jan; 116(1):110766. PubMed ID: 38141930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
